Status:
NOT_YET_RECRUITING
Evaluating Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index
Lead Sponsor:
Amway (China) R&D Center
Conditions:
Metabolic Abnormality
Metabolic Disorders
Eligibility:
All Genders
18-60 years
Brief Summary
The goal of this observational study is to evaluate Metabolic Health by fit analysis between calculated Nutrilite Metabolic Health Index and the result of Metabolomics analysis from blood plasma sampl...
Eligibility Criteria
Inclusion
- Male and female volunteers, aged 18 to 60, regardless of gender;
- Not participating in other interventional clinical studies;
- Have a good understanding of the nature, purpose, benefits obtained, and possible risks and side effects of the study;
- Willing to comply with all trial requirements and procedures;
- Sign the informed consent form.
Exclusion
- In the treatment of gastrointestinal symptoms;
- Those who are lactose intolerant, allergic to fish and their products;
- Current suffering from other organic diseases affecting bowel function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, Hirschsprung's disease, scleroderma, anorexia nervosa, etc.;
- Diet control, exercise enhancement, or taking medications that control weight or affect appetite in the past 3 months;
- Volunteers have any of the following medical history or have been clinically diagnosed with the following diseases that may affect the evaluation of the test results: obvious gastrointestinal disorders, liver, kidney, endocrine, blood, respiratory and cardiovascular diseases;
- Current or past abuse of alcohol or other illicit drugs, supplements, or OTC prescriptions 3 / 11 Research content Collection of biological samples or information data Evaluation indicators Drugs may cause intestinal dysfunction or affect the evaluation of trial effects;
- Frequent use of drugs that may affect gastrointestinal function or immune system according to the investigator's judgment.
Key Trial Info
Start Date :
October 9 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 10 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07161557
Start Date
October 9 2025
End Date
May 10 2026
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai MCC Hospital
Shanghai, Shanghai Municipality, China, 201900